US 7381405
Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
granted A61KA61K2035/124A61K2239/57
Quick answer
US patent 7381405 (Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2035/124, A61K2239/57, A61K40/11, A61K40/4234